Prevalence of and risk factors for multidrug-resistant acinetobacter baumannii colonization among high-risk nursing home residents

Infection Control and Hospital Epidemiology

Volumn 36, Issue 10, 2015, Pages 1155-1162

  Mody, Lona ^a,b   Gibson, Kristen E ^a   Horcher, Amanda ^c   Prenovost, Katherine ^d   McNamara, Sara E ^a   Foxman, Betsy ^c   Kaye, Keith S ^e   Bradley, Suzanne ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER BAUMANNII; AGED; ANTIBIOTIC RESISTANCE; ANUS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GRAM NEGATIVE BACTERIUM; HIGH RISK PATIENT; HUMAN; INGUINAL REGION; INTERVENTION STUDY; MALE; MULTICENTER STUDY; MULTIDRUG RESISTANT ACINETOBACTER BAUMANNII; NURSING HOME PATIENT; OROPHARYNX; PREVALENCE; PROSPECTIVE STUDY; PROTEUS MIRABILIS; RISK FACTOR; UNITED STATES; WOUND; ACINETOBACTER INFECTIONS; CLINICAL TRIAL; HOME FOR THE AGED; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIDRUG RESISTANCE; NURSING HOME; STATISTICAL MODEL; VERY ELDERLY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOMES FOR THE AGED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NURSING HOMES; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84956816946     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.143     Document Type: Article

References (46)

1. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007;5:939–951.
2. Albrecht MC, Griffith ME, Murray CK, et al. Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg 2006;203:546–550.
3. Dallo SF, Weitao T. Insights into Acinetobacter war-wound infections, biofilms, and control. Adv Skin Wound Care 2010;23: 169–174.
4. Charnot-Katsikas A, Dorafshar AH, Aycock JK, David MZ, Weber SG, Frank KM. Two cases of necrotizing fasciitis due to Acinetobacter baumannii. J Clin Microbiol 2009;47:258–263.
5. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases froma prospective nationwide surveillance study. Clin Infect Dis 2004;39:309–317.
6. Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents 2008;32:106–119.
7. Strausbaugh LJ, Crossley KB, Nurse BA, Thrupp LD. Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol 1996;17:129–140.
8. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006;12:826–836.
9. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003;36:1268–1274.
10. Neely AN, Maley MP, Warden GD. Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. Clin Infect Dis 1999;29:1358–1360.
11. Peleg AY, Potoski BA, Rea R, et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother 2007;59:128–131.
12. Montefour K, Frieden J, Hurst S, et al. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit Care Nurse 2008;28:15–25.
13. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46:1254–1263.
14. Furuno JP, Hebden JN, Standiford HC, et al. Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control 2008;36:468–471.
15. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751–762.
16. Wong TH, Tan BH, Ling ML, Song C. Multi-resistant Acinetobacter baumannii on a burns unit—clinical risk factors and prognosis. Burns 2002;28:349–357.
17. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century— a clinical super-challenge. N Engl J Med 2009;360:439–443.
18. Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol 2014;37:119–127.
19. Zhang D, Xia J, Xu Y, et al. Biological features of biofilm-forming ability of Acinetobacter baumannii strains derived from 121 elderly patients with hospital-acquired pneumonia. [published online December 28, 2014] Clin ExpMed. doi:10.1007/s10238-014-0333-2.
20. Luo TL, Rickard AH, Srinivasan U, Kaye KS, Foxman B. Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system [published online March 12, 2015] Front Microbiol. doi:10.3389/fmicb.2015.00182.
21. Gao J, Zhao X, Bao Y, et al. Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards. Burns 2014;40:295–299.
22. Gootz TD, Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti Infect Ther 2008;6: 309–325.
23. Richet H, Fournier PE. Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide. Infect Control Hosp Epidemiol 2006;27:645–646.
24. Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, Kaye KS.Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 2010;50:1611–1616.
25. de Medina T, Carmeli Y. The pivotal role of long-term care facilities in the epidemiology of Acinetobacter baumannii: another brick in the wall. Clin Infect Dis 2010;50:1617–1618.
26. Mortensen E, Trivedi KK, Rosenberg J, et al. Multidrug-resistant Acinetobacter baumannii infection, colonization, and transmission related to a long-term care facility providing subacute care. Infect Control Hosp Epidemiol 2014;35:406–411.
27. Bradley SF. Issues in the management of resistant bacteria in long-term-care facilities. Infect Control Hosp Epidemiol 1999;20: 362–366.
28. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538–582.
29. Pop-Vicas A, Mitchell SL, Kandel R, Schreiber R, D’Agata EM. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 2008;56: 1276–1280.
30. Muder RR, Brennen C, Goetz AM, Wagener MM, Rihs JD. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother 1991;35:256–258.
31. Muder RR, Brennen C, Drenning SD, Stout JE, Wagener MM. Multiple antibiotic-resistant gram-negative bacilli in a long-termcare facility: a case-control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol 1997;18:809–813.
32. Mody L, Bradley SF, Galecki A, et al. Conceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devices. Clin Infect Dis 2011;52:654–661.
33. Mody L, Krein SL, Saint S, et al. A targeted infection prevention intervention in nursing home residents with indwelling devices: a cluster randomized trial. [published online March 16, 2015] JAMA Intern Med. doi:10.1001/jamainternmed.2015.132.
34. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
35. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9: 179–186.
36. Wang L, Lansing B, Symons K, et al. Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices. Eur JMicrobiol Infect Dis 2012;31:1797–1804.
37. Dubois D, Grare M, Prere M, Segonds C, Marty N, Oswald E. Performances of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology. J Clin Microbiol 2012;50:2568–2576.
38. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility tests; approved standard, 11th edition. CLSI document Wayne, PA: CLSI, 2012: M02–A11.
39. Marchaim D, Chopra T, Perez F, et al. Outcomes and genetic relatedness of carbapenem-resistant Enterobacteriaceae at Detroit medical center. Infect Control Hosp Epidemiol 2011;32:861–871.
40. Marchaim D, Perez F, Lee J, et al. “Swimming in resistance”: co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. Am J Infect Control 2012;40:830–835.
41. Mammina C, Bonura C, Vivoli AR, et al. Co-colonization with carbapenem-resistant Klebsiella pneumonia and Acinetobacter baumannii in intensive care unit patients. Scand J Infect Dis 2013;45:629–634.
42. Dommeti P, Wang L, Flannery EL, Symons K, Mody L. Patterns of ciprofloxacin-resistant gram-negative bacteria colonization in nursing home residents. Infect Control Hosp Epidemiol 2011;32: 177–180.
43. Fisch J, Lansing B, Wang L, et al. New acquisition of antibioticresistant organisms in skilled nursing facilities. J Clin Microbiol 2012;50:1698–1703.
44. Min L, Galecki A, Mody L. Functional disability and nursing resource utilization are predictive of antimicrobial resistance in nursing homes. J Am Geriatr Soc 2015;63:659–666.
45. Metan G, Sariquzel F, Sumerkan B. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. Eur J Intern Med 2009;20:540–544.
46. Alsultan AA, Hamouda A, Evans BA, Amyes SG. Acinetobacter baumannii: emergence of four strains with novel bla (OXA-51-like) genes in patients with diabetes mellitus. J Chemother 2009;21: 290–295.